-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly Liabilities, Current history and change rate from Q4 2020 to Q2 2023.
- Ambrx Biopharma Cayman, Inc. Liabilities, Current for the quarter ending 30 Jun 2023 was $18.2M, a 29.4% decline year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)